Anti-cancer treatment schedule optimization based on tumor dynamics modelling incorporating evolving resistance.

Yin, Anyue; van Hasselt, Johan G C; Guchelaar, Henk-Jan; Friberg, Lena E; Moes, Dirk Jan A R

Yin, Anyue; van Hasselt, Johan G C; Guchelaar, Henk-Jan; Friberg, Lena E; Moes, Dirk Jan A R.

Afiliación

Yin A; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands.
van Hasselt JGC; Leiden Network for Personalized Therapeutics, Leiden University Medical Center, Leiden, The Netherlands.
Guchelaar HJ; Division of Systems Biomedicine and Pharmacology, Leiden Academic Centre for Drug Research (LACDR), Leiden University, Leiden, The Netherlands.
Friberg LE; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands.
Moes DJAR; Leiden Network for Personalized Therapeutics, Leiden University Medical Center, Leiden, The Netherlands.

Sci Rep ; 12(1): 4206, 2022 03 10.

Article en En | MEDLINE | ID: mdl-35273301

Asunto(s)

ADN Tumoral Circulante; Neoplasias Colorrectales; Biomarcadores de Tumor/genética; ADN Tumoral Circulante/genética; Neoplasias Colorrectales/tratamiento farmacológico; Neoplasias Colorrectales/genética; Neoplasias Colorrectales/patología; Humanos; Mutación; Estudios Prospectivos; Resultado del Tratamiento

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / ADN Tumoral Circulante Tipo de estudio: Observational_studies Límite: Humans Idioma: En Revista: Sci Rep Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google